Transcatheter closure of perimembranous ventricular septal defects.
Expert Rev Cardiovasc Ther
; 2(2): 253-64, 2004 Mar.
Article
in En
| MEDLINE
| ID: mdl-15151473
The isolated perimembranous ventricular septal defect is one of the most common congenital cardiac malformations. Although surgery has been performed and has a low associated risk, it still involves morbidity due to factors such as residual leaks, atrioventricular block, postpericardiotomy syndrome and arrhythmias. It has been speculated that percutaneous closure of these defects could minimize such complications. Recently, a device designed specifically for perimembranous ventricular septal defect closure, the Amplatzer membranous ventricular septal defect occluder, has been developed. Initial clinical experience with this device has been very encouraging with results showing a high rate of complete closure and a low incidence of complications at mid-term follow-up. In this article, the authors review their own and others' experience with this device.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiac Catheterization
/
Heart Septal Defects, Ventricular
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Expert Rev Cardiovasc Ther
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
TERAPEUTICA
Year:
2004
Document type:
Article
Affiliation country:
Brazil
Country of publication:
United kingdom